ibogaine has been researched along with tryptamine in 1 studies
| Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (tryptamine) | Trials (tryptamine) | Recent Studies (post-2010) (tryptamine) |
|---|---|---|---|---|---|
| 445 | 8 | 136 | 844 | 2 | 221 |
| Protein | Taxonomy | ibogaine (IC50) | tryptamine (IC50) |
|---|---|---|---|
| Vif | Human immunodeficiency virus 1 | 1.66 | |
| Tat | Human immunodeficiency virus 1 | 11.753 | |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 1.66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandt, SD; Caspar, A; Maurer, HH; Meyer, MR | 1 |
1 other study(ies) available for ibogaine and tryptamine
| Article | Year |
|---|---|
A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches.
Topics: Carbolines; Chromatography, Liquid; Designer Drugs; Humans; Ibogaine; Limit of Detection; Liquid-Liquid Extraction; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tryptamines; Yohimbine | 2014 |